about
High resolution melting for mutation scanning of TP53 exons 5-8Angiogenin is up-regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survivalBreast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical managementLoss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines.Phyllodes tumours of the breast: a consensus reviewAppraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breastUV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell CarcinomasLeukocyte adhesion-GPCR EMR2 is aberrantly expressed in human breast carcinomas and is associated with patient survivalVascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.Clinical cancer genomic analysis: data engineering required.VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis.The angiogenic factor thymidine phosphorylase up-regulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is associated with P-selectin expression in breast cancers.Rapid detection of carriers with BRCA1 and BRCA2 mutations using high resolution melting analysis.High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies.Detection of the transforming AKT1 mutation E17K in non-small cell lung cancer by high resolution melting.Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.No evidence for promoter region methylation of the succinate dehydrogenase and fumarate hydratase tumour suppressor genes in breast cancer.PathOS: a decision support system for reporting high throughput sequencing of cancers in clinical diagnostic laboratoriesConstitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer.A multiplex endpoint RT-PCR assay for quality assessment of RNA extracted from formalin-fixed paraffin-embedded tissues.COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatmentA high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes.The epidermal growth factor receptor in breast cancer.The bioreductive prodrug PR-104A is activated under aerobic conditions by human aldo-keto reductase 1C3.HER3 and downstream pathways are involved in colonization of brain metastases from breast cancerBreast cancer prognostic classification in the molecular era: the role of histological grade.Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium.Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor alpha and improved survival in primary human breast carcinomas.High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer.Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas.Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs.Thymidine phosphorylase is angiogenic and promotes tumor growth.Mutational profiling of familial male breast cancers reveals similarities with luminal A female breast cancer with rare TP53 mutations.A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma.Blood vessel invasion and other variables as predictors of long-term survival in Japanese and British patients with primary invasive breast cancer.Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours.Triple negative breast cancers have a reduced expression of DNA repair genesA fully human inhibitory monoclonal antibody to the Wnt receptor RYKLoss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status.
P50
Q21260416-644C2FCF-FB4F-4CE4-B28A-4522F4F2EC5AQ24298434-23A450A7-DA33-4E8F-BB0A-2A4A8614882AQ26782664-D330DC05-1EE2-4F7A-9407-64B70163B9BCQ27852814-7226855F-4C5A-49C1-BFAF-8A4251D99C1CQ28079009-609BE613-302D-47C7-9BC4-9B1BFE858386Q28083103-9C039C65-1BD4-4543-B8EF-51C6CE621C6BQ28270523-8B595F2B-BF04-425E-8839-2D0D8CD4E81BQ28301490-5B1377B3-D550-4F32-988D-EF22094F1D02Q30986841-9B034B48-23A0-45C6-8169-51932649D904Q30993567-00493DFF-270E-468D-B260-0A3CCD7CE289Q32161271-C7966588-8AAC-48D6-A6AD-11AA62C9C41BQ33284027-F27DF7D5-7BC5-444E-95BD-AC2372E3C763Q33321039-4338295E-F1E6-4E23-BDD3-F8B1C194A618Q33336861-4551E2CE-A7DD-453A-B965-2EA15075EA19Q33350101-2B4F7142-8377-4712-B7F0-33AC1B340B37Q33359495-CFDF0A18-5D6C-4255-8D56-531FA80EC56DQ33506548-FEF3D7EC-3A26-40FC-ACEF-E9EA38B0E9E5Q33602117-01A20908-8628-46FC-A391-1F6CBDCC2A58Q33646285-1F5C3C58-9EC2-4C1D-99ED-9179F76A3722Q33772894-1390E650-8C0A-473A-BCDA-04FD554E508AQ33877411-6C003437-8CBC-4D58-8E46-7544B56CB89DQ33942332-BA86088E-99E7-42F7-AEEC-E5961BBCE715Q33959323-F1F4EB8C-42F2-4611-84C4-52C13FDC6909Q34097892-7ACEAF8F-401F-45FC-8699-D1348966938DQ34173413-8BC49571-A414-4D8F-B003-1E405307DA97Q34173440-01B3E01B-7FE5-43C0-BEFD-E438574885BEQ34193953-8AF6003F-B332-4419-A69C-CA0F7D5DA698Q34254937-6BE2CD53-AE6B-4E80-91DD-4038CE4FB3B8Q34322836-411C6C37-2FF5-4E01-B503-C42D48B37A46Q34433513-676413A2-F476-4F20-8F60-5A752E8D4C9BQ34475135-46AADB5C-FE7C-40D2-9FD2-9FF69650022AQ34572035-0303862C-9FEB-465A-A94A-E398D88CC845Q34672542-0D8083A0-05B4-40CB-BFAB-AAC3E9281B3DQ34686985-C23611EE-3491-4633-B511-2F52820BC975Q34687036-C4C6BC0F-9880-4B4C-B35A-793885A36BAFQ34733112-4FAA6E85-7113-4EB6-927C-4A95B034BA2DQ34762171-4218D9CF-9861-445C-80A9-1D229B3AA330Q34794035-85CA912E-A598-4028-81F0-C2786CD38F55Q34995094-5E751EC9-CC77-4346-9541-4507520D2510Q34997125-F726D8BA-97F2-460A-B218-A78FBFD8697C
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stephen B Fox
@nl
Stephen B Fox
@sl
Stephen B. Fox
@en
Stephen B. Fox
@es
Stephen Fox
@fr
type
label
Stephen B Fox
@nl
Stephen B Fox
@sl
Stephen B. Fox
@en
Stephen B. Fox
@es
Stephen Fox
@fr
altLabel
SB Fox
@en
Stephen B. Fox
@en
prefLabel
Stephen B Fox
@nl
Stephen B Fox
@sl
Stephen B. Fox
@en
Stephen B. Fox
@es
Stephen Fox
@fr
P1053
G-9719-2016
P106
P1153
7401924665
P21
P31
P3829
P496
0000-0002-7648-8896